Segment Information (Tables)

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Revenue by Reportable Segment

The following table presents revenue for each reportable segment and Corporate:

	Three Months Ended September 30,
(in millions)	2017			2016
Pharmaceutical	$	28,920		$	28,762
Medical	3,724			3,279
Total segment revenue	32,644			32,041
Corporate (1)	(3		)	(2		)
Total revenue	$	32,641		$	32,039

(1) Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

	Three Months Ended September 30,
(in millions)	2017			2016
Pharmaceutical	$	467		$	534
Medical	129			127
Total segment profit	596			661
Corporate	(334		)	(126		)
Total operating earnings	$	262		$	535

Assets by Reportable Segment

(in millions)	September 30, 2017		June 30, 2017
Pharmaceutical	$	22,220	$	21,848
Medical	18,055		10,688
Corporate	1,665		7,576
Total assets	$	41,940	$	40,112